The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Propagation of Tau Misfolding from the Outside to the Inside of a Cell
Open accessAbstract
Tauopathies are neurodegenerative diseases characterized by aggregation of the microtubule-associated protein Tau in neurons and glia. Although Tau is normally considered an intracellular protein, Tau aggregates are observed in the extracellular space, and Tau peptide is readily detected in the cerebrospinal fluid of patients. Tau aggregation occurs in many diseases, including Alzheimer disease and frontotemporal dementia. Tau pathology begins in discrete, disease-specific regions but eventually involves much larger areas of the brain. It is unknown how this propagation of Tau misfolding occurs. We hypothesize that extracellular Tau aggregates can transmit a misfolded state from the outside to the inside of a cell, similar to prions. Here we show that extracellular Tau aggregates, but not monomer, are taken up by cultured cells. Internalized Tau aggregates displace tubulin, co-localize with dextran, a marker of fluid-phase endocytosis, and induce fibrillization of intracellular full-length Tau. These intracellular fibrils are competent to seed fibril formation of recombinant Tau monomer in vitro. Finally, we observed that newly aggregated intracellular Tau transfers between co-cultured cells. Our data indicate that Tau aggregates can propagate a fibrillar, misfolded state from the outside to the inside of a cell. This may have important implications for understanding how protein misfolding spreads through the brains of tauopathy patients, and it is potentially relevant to myriad neurodegenerative diseases associated with protein misfolding.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Pathogenic forms of tau spread toxicity between cells through a prion-like mechanism involving seeded conformational change (Colin et al. 2020, Frost et al. 2009).”
From The Role of Retrotransposons and Endogenous Retroviruses in Age-Dependent Neurodegenerative Disorders (2024) · cites this paper as Frost et al. 2009
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Several lines of evidence indicate tau propagates pathology among neurons.”
From Spontaneous pathology in PS19 tauopathy mice progresses via brain networks (2025) · cites this paper as Frost et al., 2009
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Proteopathic tau seeds are capable of entering a cell and promoting aggregation in a prion-like manner (Clavaguera et al., 2009; Frost et al., 2009).”
From Network analysis identifies strain-dependent response to tau and tau seeding-associated genes (2023) · cites this paper as Frost et al., 2009
The cited source says what the claim attributes to it.
In the citing paper
“Tau assemblies enter cells to trigger intracellular aggregation (Frost et al., 2009; Holmes et al., 2014)”
From Spontaneous pathology in PS19 tauopathy mice progresses via brain networks (2025) · cites this paper as Frost et al., 2009
In the citing paper
“The aggregation of tau impairs the axons, leading to neurodegeneration [23].”
From The Multifaceted Role of Neuroprotective Plants in Alzheimer’s Disease Treatment (2022) · cites this paper as [23]
In the citing paper
“The current clinical trial literature is compatible with the idea that AβP-related substances kindle a self-propagating process related to neocortical NFTs, as has been hypothesized (266-269).”
From Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature (2012) · cites this paper as [267]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Inflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514
Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
Hutton, M., Lendon, C. L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A., et al. (1998) · Nature · doi:10.1038/31508 · Cited by 3,498
A protein factor essential for microtubule assembly
Weingarten, M. D., Lockwood, A. H., Hwo, S. Y., & Kirschner, M. W. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.5.1858 · Cited by 3,089
Lee, V. M.-Y., Goedert, M., & Trojanowski, J. Q. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.1121 · Cited by 2,480
Frequency of Stages of Alzheimer-Related Lesions in Different Age Categories
Braak, H., & Braak, E. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00056-0 · Cited by 1,656
Mutation in the tau gene in familial multiple system tauopathy with presenile dementia
Spillantini, M. G., Murrell, J. R., Goedert, M., Farlow, M. R., Klug, A., & Ghetti, B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7737 · Cited by 1,474
Arnold, S. E., Hyman, B. T., Flory, J., Damasio, A. R., & Van Hoesen, G. W. (1991) · Cerebral Cortex · doi:10.1093/cercor/1.1.103 · Cited by 1,380
Tau is a candidate gene for chromosome 17 frontotemporal dementia
Poorkaj, P., Bird, T. D., Wijsman, E., Nemens, E., Garruto, R. M., Anderson, L., Andreadis, A., Wiederholt, W. C., Raskind, M., & Schellenberg, G. D. (1998) · Annals of Neurology · doi:10.1002/ana.410430617 · Cited by 1,374
Flagged first, then by citations
Research works printed but not linked: 2
- Delacourte, 2005, Polish Acad. Sci., 43, 244
- DePace, 2002, Nat. Struct. Biol., 9, 389
Cited by
Sorted by citations
Items 801–900 of 1,001
Prognostic role of “prion-like propagation” in SOD1-linked familial ALS: an alternative view
Sugaya, K., & Nakano, I. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00359 · Cited by 16
Wauters, M., Wattiez, R., & Ris, L. (2016) · Biomolecules · doi:10.3390/biom6030036 · Cited by 15
Synucleinopathies and Tauopathies
Goedert, M., & Spillantini, M. G. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-374947-5.00047-x · Cited by 15
Disease-modifying strategies in primary tauopathies
Rösler, T. W., Costa, M., & Höglinger, G. U. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.107842 · Cited by 16
Astroski, J. W., Akporyoe, L. K., Androphy, E. J., & Custer, S. K. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.01.003 · Cited by 14
Immunothrombosis in neurovascular disease
Denorme, F., Ajanel, A., & Campbell, R. A. (2023) · Research and Practice in Thrombosis and Haemostasis · doi:10.1016/j.rpth.2023.102298 · Cited by 15
Complement receptor 4 mediates the clearance of extracellular tau fibrils by microglia
Yoo, C. J., Choi, Y., Bok, E., Lin, Y., Cheon, M., Lee, Y., & Kim, J. (2024) · FEBS Journal · doi:10.1111/febs.17150 · Cited by 16
Human Serum Albumin-Inspired Glycopeptide-Based Multifunctional Inhibitor of Amyloid-β Toxicity
Roy, R., Pradhan, K., Khan, J., Das, G., Mukherjee, N., Das, D., & Ghosh, S. (2020) · ACS Omega · doi:10.1021/acsomega.0c01028 · Cited by 14
Cell-free amplification of prions: Where do we stand?
Cazzaniga, F. A., Luca, C. M. G. D., Bistaffa, E., Consonni, A., Legname, G., Giaccone, G., & Moda, F. (2020) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2020.08.005 · Cited by 14
Proteomics for comprehensive characterization of extracellular vesicles in neurodegenerative disease
Vinaiphat, A., & Sze, S. K. (2022) · Experimental Neurology · doi:10.1016/j.expneurol.2022.114149 · Cited by 14
Lim, S., Shin, S., Sung, Y., Lee, H. E., Kim, K. H., Song, J. Y., Lee, G., Aziz, H., Lukianenko, N., Kang, D. M., et al. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-00959-5 · Cited by 16
Context dependence of protein misfolding and structural strains in neurodegenerative diseases
Mehta, A. K., Rosen, R. F., Childers, W. S., Gehman, J. D., Walker, L. C., & Lynn, D. G. (2013) · Biopolymers · doi:10.1002/bip.22283 · Cited by 14
Schierle, G. S. K., Michel, C. H., & Gasparini, L. (2016) · Microscopy Research and Technique · doi:10.1002/jemt.22698 · Cited by 14
Ferrer, I., Andrés‐Benito, P., Sala‐Jarque, J., Gil, V., & del Rı́o, J. A. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.00101 · Cited by 14
Misfolded protein aggregation and altered cellular pathways in neurodegenerative diseases
Li, H., Yu, Z., & Zhang, W. (2020) · STEMedicine · doi:10.37175/stemedicine.v1i4.63 · Cited by 14
Biology and Genetics of PrP Prion StrainsPreprint
Ghaemmaghami, S. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026922 · Cited by 14
Chaperone-Mediated Regulation of Tau Phase Separation, Fibrillation, and Toxicity
Mörman, C., Leppert, A., Pizzirusso, G., Zheng, Z., Sun, X., Kumar, R., Biverstål, H., Landreh, M., Johansson, J., Arroyo‐García, L. E., et al. (2025) · Journal of the American Chemical Society · doi:10.1021/jacs.5c01369 · Cited by 14
Huhe, H., Shapley, S. M., Duong, D. M., Wu, F., Ha, S.-K., Choi, S., Kofler, J., Mou, Y., Guimarães, T. R., Thathiah, A., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14366 · Cited by 12
Sandhof, C. A., Murray, H. F. B., Silva, M. C., & Haggarty, S. J. (2024) · Neurotherapeutics · doi:10.1016/j.neurot.2024.e00499 · Cited by 14
Tau uptake by human neurons depends on receptor LRP1 and kinase LRRK2
Evans, L. D., Strano, A., Tuck, E., Campbell, A., Smith, J., Hung, C., Behr, T. S., Ghetti, B., Ryskeldi-Falcon, B., Karakoc, E., et al. (2025) · The EMBO Journal · doi:10.1038/s44318-025-00514-0 · Cited by 16
Tau Protein in Oral Mucosa and Cognitive State: A Cross-sectional Study
Arredondo, L. F., Aranda‐Romo, S., Rodríguez‐Leyva, I., Chi-Ahumada, É., Saikaly, S. K., Portales‐Pérez, D. P., González‐Amaro, R., Salgado‐Bustamante, M., Enríquez‐Macías, L., Eng, W., et al. (2017) · Frontiers in Neurology · doi:10.3389/fneur.2017.00554 · Cited by 13
Grames, M. S., Dayton, R. D., Jackson, K. L., Richard, A. D., Lu, X., & Klein, R. L. (2018) · The FASEB Journal · doi:10.1096/fj.201701529rr · Cited by 12
The Role of Vesicle Trafficking Defects in the Pathogenesis of Prion and Prion-Like Disorders
Cherry, P., & Gilch, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197016 · Cited by 14
A feature analysis of lower solubility proteins in three eukaryotic systems
Albu, R. F., Chan, G. T., Zhu, M., Wong, E. T. C., Taghizadeh, F., Hu, X., Mehran, A. E., Johnson, J. D., Gsponer, J. A., & Mayor, T. (2014) · Journal of Proteomics · doi:10.1016/j.jprot.2014.10.011 · Cited by 14
Prolonged nitric oxide treatment induces tau aggregation in SH-SY5Y cells
Takahashi, M., Chin, Y., Nonaka, T., Hasegawa, M., Watanabe, N., & Arai, T. (2012) · Neuroscience Letters · doi:10.1016/j.neulet.2011.12.067 · Cited by 13
Varghese, M., Santa‐María, I., Ho, L., Ward, L. M., Yemul, S., Dubner, L., Ksiȩżak-Reding, H., & Pasinetti, G. M. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160166 · Cited by 14
Our Working Point of View of Tau Protein
Ávila, J. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170600 · Cited by 14
The role of wild-type tau in Alzheimer’s disease and related tauopathies
Lo, C. H., & Sachs, J. N. (2020) · JoLS Journal of Life Sciences · doi:10.36069/jols/20201201 · Cited by 15
Sequence-dependent abnormal aggregation of human Tau fragment in an inducible cell model
Liu, X., Hu, J.-Y., Hu, M.-Y., Zhang, Y., Hong, Z., Cheng, X., Chen, J., Pang, D., & Liang, Y. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.04.015 · Cited by 13
Generation, Purification, and Characterization of Cell-invasive DISC1 Protein Species
Bader, V., Ottis, P., Pum, M. E., Huston, J. P., & Korth, C. (2012) · Journal of Visualized Experiments · doi:10.3791/4132 · Cited by 13
Macrocyclic β-arch peptides that mimic the structure and function of disease-associated tau folds
Angera, I. J., Xu, X., Rajewski, B. H., Hallinan, G. I., Zhang, X., Ghetti, B. F., Vidal, R., Jiang, W., & Valle, J. R. D. (2025) · Nature Chemistry · doi:10.1038/s41557-025-01805-z · Cited by 12
Oligomerization by co-assembly of β-amyloid and α-synuclein
Kim, J. R. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1153839 · Cited by 13
A philosophy of science approach to the amyloid hypothesis of Alzheimer's disease
Daly, T. P. (2024) · European Journal of Neuroscience · doi:10.1111/ejn.16500 · Cited by 14
Unknown roles of tau pathology in neurological disorders. Challenges and new perspectives
Olesen, M. A., Villavicencio-Tejo, F., Cuevas-Espinoza, V., & Quintanilla, R. A. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102594 · Cited by 12
Molecular Insights into Tau Pathology and its Therapeutic Strategies in Alzheimer's Disease
Zhou, F., Zhao, Y., Sun, Y., & Chen, W. (2024) · Journal of Integrative Neuroscience · doi:10.31083/j.jin2311197 · Cited by 13
Böken, D., Wu, Y., Zhang, Z.-W., & Klenerman, D. (2024) · ChemBioChem · doi:10.1002/cbic.202400877 · Cited by 11
Huang, M., & McEwan, W. A. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.108245 · Cited by 12
Wang, S., Qi, C., Rajpurohit, C. S., Ghosh, B., Xiong, W., Wang, B., Qi, Y., Hwang, S. H., Hammock, B. D., Li, H., et al. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00844-x · Cited by 16
The P’s and Q’s of cellular PrP-Aβ interactions
Westaway, D. A., & Jhamandas, J. H. (2012) · Prion · doi:10.4161/pri.20675 · Cited by 13
Clinical correlates to assist with chronic traumatic encephalopathy diagnosis
Thomsen, G. M., Ko, A., Harada, M. Y., Ma, A., Wyss, L. S., Haro, P. S., Vit, J., Avalos, P., Dhillon, N. K., Cho, N., et al. (2017) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0000000000001443 · Cited by 13
Spreading of Tau Protein Does Not Depend on Aggregation Propensity
Rodrigues, S., Anglada‐Huguet, M., Hochgräfe, K., Kaniyappan, S., Wegmann, S., & Mandelkow, E. (2023) · Journal of Molecular Neuroscience · doi:10.1007/s12031-023-02143-w · Cited by 12
Nam, W., & Choi, Y. P. (2018) · Prion · doi:10.1080/19336896.2018.1545524 · Cited by 13
Strain-specific clearance of seed-dependent tau aggregation by lithium-induced autophagy
Uddin, M. N., Elahi, M., Shimonaka, S., Kakuta, S., Ishiguro, K., Motoi, Y., & Hattori, N. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.12.113 · Cited by 12
N-Amination Converts Amyloidogenic Tau Peptides into Soluble Antagonists of Cellular Seeding
Makwana, K. M., Sarnowski, M. P., Miao, J., Lin, Y., & Valle, J. R. D. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00528 · Cited by 12
Structure‐oriented review of 14‐3‐3 protein isoforms in geriatric neuroscience
Umahara, T., Uchihara, T., & Iwamoto, T. (2012) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/j.1447-0594.2012.00860.x · Cited by 12
Spreading proteins in neurodegeneration: where do they take us?
Mallucci, G. R. (2013) · Brain · doi:10.1093/brain/awt072 · Cited by 12
α-Linolenic acid modulates phagocytosis of extracellular Tau and induces microglial migrationPreprint
Desale, S. E., & Chinnathambi, S. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.04.15.042143 · Cited by 12
Tau expression and phosphorylation in enteroendocrine cells
Chapelet, G., Béguin, N., Castellano, B., Grit, I., de Coppet, P., Oullier, T., Neunlist, M., Blottière, H. M., Rolli‐Derkinderen, M., Dréan, G. L., et al. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1166848 · Cited by 13
Gharai, P. K., Khan, J., Pradhan, K., Mallesh, R., Garg, S., Arshi, M. U., Barman, S., & Ghosh, S. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00777 · Cited by 11
Advancing Nanomaterial-Based Strategies for Alzheimer’s Disease: A Perspective
Zhou, H., Yin, X., Zhang, G., Yang, Z., & Zhou, R. (2025) · JACS Au · doi:10.1021/jacsau.5c00002 · Cited by 15
Life cycle of cytosolic prions
Hofmann, J. P., & Vorberg, I. M. (2013) · Prion · doi:10.4161/pri.26414 · Cited by 11
Untangling the role of tau in Alzheimer’s disease: A unifying hypothesis
Bhatia, N. S., & Hall, G. F. (2013) · Translational Neuroscience · doi:10.2478/s13380-013-0114-5 · Cited by 11
Transmission of Tau Pathology Induced by Synthetic Preformed Tau Filaments
Reyes, J. F., Rey, N. L., & Angot, É. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.0725-13.2013 · Cited by 11
In vitro study of the mechanism of intraneuronal β-amyloid aggregation in Alzheimer’s disease
Alsunusi, S., Kumosani, T., Glabe, C. G., Huwait, E. A., & Moselhy, S. S. (2020) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2020.1722707 · Cited by 11
Amylin and Secretases in the Pathology and Treatment of Alzheimer’s Disease
Singh, S. P., Yang, F., Sivils, A., Cegielski, V., & Chu, X. (2022) · Biomolecules · doi:10.3390/biom12070996 · Cited by 11
Role of Tau protein in long COVID and potential therapeutic targets
Marwaha, B. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1280600 · Cited by 11
LaCroix, M., Artikis, E., Hitt, B. D., Beaver, J. D., Estill, S. J., Gleason, K., Tamminga, C. A., Evers, B. M., White, C. L., Caughey, B. W., et al. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.105545 · Cited by 11
Self-citationThe Potential of a Stratified Approach to Drug Repurposing in Alzheimer’s Disease
Anderson, C., Bucholc, M., McClean, P. L., & Zhang, S. (2023) · Biomolecules · doi:10.3390/biom14010011 · Cited by 13
Strain Specificity and Drug Resistance in Anti-Prion Therapy
Miller-Vedam, L. E., & Ghaemmaghami, S. (2013) · Current Topics in Medicinal Chemistry · doi:10.2174/15680266113136660168 · Cited by 11
Longitudinal Assessment of a Transgenic Animal Model of Tauopathy by FDG-PET Imaging
de Cristóbal, J., García‐García, L., Delgado, M., Pérez, M., Pozo, M. A., & Medina, M. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-132276 · Cited by 11
Wang, R., Yang, X. H., Cui, L., Yin, H., & Xu, S. (2019) · Biomolecules · doi:10.3390/biom9060210 · Cited by 11
Vogels, T., Vargová, G., Brezováková, V., Quint, W. H., & Hromádka, T. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200047 · Cited by 11
Schmidt, S., Stapf, C. D., Schmutzler, S., Lachmann, I., Arendt, T., Holzer, M., Sonntag, M., & Morawski, M. (2020) · European Journal of Neuroscience · doi:10.1111/ejn.14923 · Cited by 11
Quantitative Methods for the Detection of Tau Seeding Activity in Human Biofluids
Lathuilière, A., & Hyman, B. T. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.654176 · Cited by 13
Phosphorylation of Truncated Tau Promotes Abnormal Native Tau Pathology and Neurodegeneration
Li, L., Jiang, Y., Wu, G., Mahaman, Y. A. R., Ke, D., Wang, Q., Zhang, B., Wang, J., Li, H., Liu, R., et al. (2021) · Molecular Neurobiology · doi:10.1007/s12035-022-02972-7 · Cited by 11
Vigers, M. P., Lobo, S., Najafi, S., DuBose, A., Tsay, K., Ganguly, P., Longhini, A. P., Jin, Y., Buratto, S. K., Kosik, K. S., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.11.28.568818 · Cited by 11
Sala‐Jarque, J., Zimkowska, K., Ávila, J., Ferrer, I., & del Río, J. A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911527 · Cited by 11
Carles, A., Freyssin, A., Guehairia, S., Reguero, T., Vignes, M., Hirbec, H., Rubinstenn, G., & Maurice, T. (2025) · Alzheimer s Research & Therapy · doi:10.1186/s13195-024-01648-9 · Cited by 12
Kaniuk, J. K., Kumar, D., Mazurek, C. Y., Khavari, S., Sollenberger, C. H., Ahuja, A., Mossner, J. M., & Ahuja, C. S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26157191 · Cited by 11
Protein Misfolding Cyclic Amplification
Moda, F., Pritzkow, S., & Soto, C. A. (2012) · Springer eBooks · doi:10.1007/978-1-4614-5305-5_6 · Cited by 10
Ferrer, I., Andrés‐Benito, P., Carmona, M., & del Rı́o, J. A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232415940 · Cited by 10
Awasthi, A., Bhaskar, S., Panda, S., & Roy, S. (2024) · Brain Multiphysics · doi:10.1016/j.brain.2024.100090 · Cited by 10
HIV Glycoprotein Gp120 Impairs Fast Axonal Transport by Activating Tak1 Signaling Pathways
Berth, S. H., Mesnard, N. A., Wang, B., Kim, H., Song, Y., Sapar, M. L., Morfini, G. A., & Brady, S. T. (2016) · ASN NEURO · doi:10.1177/1759091416679073 · Cited by 10
Li, X., Jia, Y., Li, J., Zhang, P., Li, T., Lu, L., Yao, H., Liu, J., Zhu, Z., & Xu, J. (2022) · Molecules · doi:10.3390/molecules27103090 · Cited by 10
Protein Misfolding Cyclic Amplification of Infectious Prions
Moda, F. (2017) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2017.06.016 · Cited by 10
Strains of Pathological Protein Aggregates in Neurodegenerative Diseases
Wang, X., Noroozian, Z., Lynch, M., Armstrong, N., Schneider, R., Liu, M., Ghodrati, F., Zhang, A. B., Yang, Y. J., Hall, A. C., et al. (2017) · Discoveries · doi:10.15190/d.2017.8 · Cited by 11
Imaging FITC-dextran as a Reporter for Regulated Exocytosis
Klein, O., Roded, A., Hirschberg, K., Fukuda, M., Galli, S. J., & Sagi‐Eisenberg, R. (2018) · Journal of Visualized Experiments · doi:10.3791/57936 · Cited by 10
Balana, A. T., Mahul‐Mellier, A., Nguyen, B. A., Horvath, M., Javed, A., Hard, E. R., Jasiqi, Y., Singh, P., Afrin, S., Pedretti, R., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.03.07.531573 · Cited by 10
Cathepsin-dependent amyloid formation drives mechanical rupture of lysosomal membranesPreprint
Li, D., Zhang, W., Medina, M., Stuke, J. F. M., Schwarz, A., Brill, J., Brenner, J., Kraus, F., Ohlerich, S., Lizarrondo, J., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.01.17.700056 · Cited by 15
Cell-to-cell transfer of SAA1 protein in a cell culture model of systemic AA amyloidosis
Claus, S., Puşcalău-Gîrţu, I., Walther, P., Syrovets, T., Simmet, T., Haupt, C., & Fändrich, M. (2017) · Scientific Reports · doi:10.1038/srep45683 · Cited by 9
Arastoo, M., Penny, L. K., Lofthouse, R. A., Abdallah, A., Abrahamsson, A., Marini, P., Melis, V., Riedel, G., Harrington, C. R., Wischik, C. M., et al. (2024) · Alzheimer s Research & Therapy · doi:10.1186/s13195-024-01561-1 · Cited by 9
Opportunities for Conformation-Selective Antibodies in Amyloid-Related Diseases
Westwood, M., & Lawson, A. D. G. (2015) · Antibodies · doi:10.3390/antib4030170 · Cited by 9
Drug Development for Neurodegenerative Diseases
Nagai, Y., & Minakawa, E. N. (2015) · Springer eBooks · doi:10.1007/978-4-431-54541-5_9 · Cited by 8
Klaver, A. C., Coffey, M. P., Bennett, D. A., & Loeffler, D. A. (2017) · Translational Neurodegeneration · doi:10.1186/s40035-017-0100-x · Cited by 9
Computational modelling of pathogenic protein spread in neurodegenerative diseases
Georgiadis, K. L., Wray, S., Sebastien Ourselin, A., Warren, J. D., & Marc Modat, A. (2018) · PLoS ONE · doi:10.1371/journal.pone.0192518 · Cited by 9
Venkataraman, L., He, P., Schulz, P., & Sierks, M. R. (2020) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2020.04.014 · Cited by 9
Vitale, F., Ortolan, J., Volpe, B. T., Marambaud, P., Giliberto, L., & d’Abramo, C. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-01003-7 · Cited by 9
Huang, X., Li, T., Zhou, L., Liu, T., Xiong, L., & Yu, C. (2021) · Ibrain · doi:10.1002/j.2769-2795.2021.tb00060.x · Cited by 11
Tau Protein as a Biological Fluid Biomarker in Neurodegenerative Dementias
Llorens, F., Villar‐Piqué, A., Candelise, N., Ferrer, I., & Zerr, I. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.73528 · Cited by 10
Endogenous pathology in tauopathy mice progresses via brain networksPreprint
Ramirez, D. M. O., Whitesell, J. D., Bhagwat, N., Thomas, T. L., Ajay, A. D., Nawaby, A., Delatour, B., Bay, S., Lafaye, P. J., Knox, J. E., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.05.23.541792 · Cited by 9
Self-citationChronic Neuronal Hyperexcitation Exacerbates Tau Propagation in a Mouse Model of Tauopathy
Nishida, I., Yamada, K., Sakamoto, A., Wakabayashi, T., & Iwatsubo, T. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25169004 · Cited by 8
Tian, S., Liu, Y., Hong, H., & Li, S. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05280-y · Cited by 8
Karabova, M. K., del Ser‐Badia, A., Hedegaard, A., Washer, S. J., Baykam, Z., O'Brien, D. P., Vendrell, I., Hester, S., Fischer, R., Johnson, E., et al. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71337 · Cited by 10
The role of prion strain diversity in the development of successful therapeutic treatments
Holec, S. A. M., Block, A. J., & Bartz, J. C. (2020) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2020.07.001 · Cited by 8
The Adult Neurogenesis Theory of Alzheimer’s Disease
Abbate, C. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-221279 · Cited by 11
Saez-Calveras, N., Vaquer‐Alicea, J., White, C. L., Tak, Y., Cosentino, S., Faust, P. L., Louis, E. D., & Diamond, M. I. (2025) · Acta Neuropathologica · doi:10.1007/s00401-024-02843-6 · Cited by 9
Self-citationSábado, J., Casanovas, A., Rodrigo, H. M., Arqué, G., & Esquerda, J. E. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.09.027 · Cited by 8
Kanaan, N. M., Himmelstein, D. S., Ward, S., Combs, B., & Binder, L. I. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-405195-9.00056-1 · Cited by 9
Therapeutic applications of antibodies in non-infectious neurodegenerative diseases
Krishnamurthy, P., & Sigurdsson, E. M. (2011) · New Biotechnology · doi:10.1016/j.nbt.2011.03.020 · Cited by 8
Fressinaud, C., Thomas, O., Umerska, A. M., & Saulnier, P. (2020) · Neurochemical Research · doi:10.1007/s11064-020-03122-y · Cited by 8
Metadata
- Authors
- Frost, B., Jacks, R. L., & Diamond, M. I.
- Affiliations
- University of California, San Francisco (US)
- Corresponding author
- Diamond, Marc I.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2009-05
- Volume
- 284
- Issue
- 19
- Pages
- 12845-12852
- ISSN
- 0021-9258 (ISSN-L)
- PMC
- PMC2676015
- OpenAlex
- W1989208474
- Cited by
- 1,252
- References
- 32
- Citations by year
- 2026: 34 · 2025: 71 · 2024: 76 · 2023: 78 · 2022: 72 · 2021: 96 · 2020: 97 · 2019: 70 · 2018: 67 · 2017: 76 · 2016: 67 · 2015: 83 · 2014: 78 · 2013: 89 · 2012: 81
- FWCI
- 43.07
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Muscular Dystrophy Association
- National Institutes of Health
- University of California, San Francisco
- National Institute of Neurological Disorders and Stroke (R01NS050284, R01 NS50284-03)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Prion Diseases and Protein Misfolding
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- tauopathy, prion-like propagation, fluid-phase endocytosis, Alzheimer's disease, frontotemporal dementia
- MeSH terms
- Animals, Animals, Newborn, Cell Line, Dextrans, Extracellular Space, Flow Cytometry, Fluorescent Antibody Technique, Humans, Kidney, Luminescent Proteins, Neurons, Stem Cells, Blotting, Western, tau Proteins, Protein Folding, Microscopy, Atomic Force, Coculture Techniques, Intracellular Space, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
